When AI Meets Biotech, the Results Are Amazing - and Profitable

Leave a Reply Click here to cancel reply. Your email address will not be published. In biotech, one thing isn't going to change. The treatment that makes up 90% of the pharmaceutical market – good, old-fashioned small molecules created in the laboratory – isn't going anywhere. Yes, incredibly innovative treatments like T-cell therapy, microbiome therapies, and CRISPR gene editing are all having a huge impact on healthcare.